首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   223篇
  免费   13篇
林业   9篇
  9篇
综合类   18篇
农作物   5篇
水产渔业   15篇
畜牧兽医   170篇
园艺   7篇
植物保护   3篇
  2024年   4篇
  2023年   3篇
  2022年   4篇
  2021年   11篇
  2020年   7篇
  2019年   13篇
  2018年   7篇
  2017年   11篇
  2016年   3篇
  2015年   7篇
  2014年   7篇
  2013年   7篇
  2012年   28篇
  2011年   27篇
  2010年   8篇
  2009年   9篇
  2008年   8篇
  2007年   22篇
  2006年   21篇
  2005年   6篇
  2004年   5篇
  2003年   6篇
  2002年   8篇
  2000年   1篇
  1990年   2篇
  1977年   1篇
排序方式: 共有236条查询结果,搜索用时 31 毫秒
161.
Registration schemes for plant-protection products require applicants to assess the potential ecological risk of their products using a tiered approach. Standard aquatic ecotoxicity tests are used at lower tiers and clearly defined methodologies are available for assessing the potential environmental risks. Safety factors are incorporated into the assessment process to account for the uncertainties associated with the use of lower-tier single-species ecotoxicity studies. If lower-tier assessments indicate that a substance may pose a risk to the environment, impacts can be assessed using more environmentally realistic conditions through the use of either pond mesocosms, artificial streams or field monitoring studies. Whilst these approaches provide more realistic assessments, the results are difficult to interpret and extrapolation to other systems is problematic. Recently it has been recognised that laboratory approaches that are intermediate between standard aquatic toxicity tests and field/mesocosm studies may provide useful data and help reduce the uncertainties associated with standard single-species tests. However, limited guidance is available on what tests are available and how they can be incorporated into the risk-assessment process. This paper reviews a number of these higher-tier laboratory techniques, including modified exposure studies, species sensitivity studies, population studies and tests with sensitive life stages. Recommendations are provided on how the approaches can be incorporated into the risk-assessment process.  相似文献   
162.
163.
164.
165.

Objective

To study the influence of pain on the pharmacokinetics and anti-inflammatory actions of transdermal flunixin administered at dehorning.

Study design

Prospective, crossover, clinical study.

Animals

A total of 16 male Holstein calves, aged 6–8 weeks weighing 61.3 ± 6.6 kg.

Methods

Calves were randomly assigned to one of two treatments: transdermal flunixin and dehorning (PAIN) or transdermal flunixin and sham dehorning (NO PAIN). Flunixin meglumine (3.33 mg kg?1) was administered topically as a pour-on concurrently with hot iron dehorning or sham dehorning. The calves were subjected to the alternative treatment 14 days later. Blood samples were collected at predetermined time points up to 72 hours for measurement of plasma flunixin concentrations. Pharmacokinetics parameters were determined using noncompartmental analysis. Prostaglandin E2 (PGE2) concentration was determined using a commercial enzyme-linked immunosorbent assay. The 80% inhibition concentration (IC80) of PGE2 was determined using nonlinear regression. Pharmacokinetic data were statistically analyzed using paired t tests and Wilcoxon rank sums for nonparametric data. Flunixin and PGE2 concentrations were log transformed and analyzed using repeated measures.

Results

A total of 15 calves completed the study. Plasma half-life of flunixin was significantly longer in PAIN (10.09 hours) than NO PAIN (7.16 hours) (p = 0.0202). Bioavailability of transdermal flunixin was 30% and 37% in PAIN and NO PAIN, respectively (p = 0.097). Maximum plasma concentrations of flunixin were 0.95 and 1.16 μg mL?1 in PAIN and NO PAIN, respectively (p = 0.089). However, there was a treatment (PAIN versus NO PAIN) by time interaction (p = 0.0353). PGE2 concentrations were significantly lower in the PAIN treatment at 48 and 72 hours (p = 0.0092 and p = 0.0287, respectively). The IC80 of PGE2 by flunixin was similar in both treatments (p = 0.88).

Conclusion and clinical relevance

Pain alters the pharmacokinetics and anti-inflammatory effects of transdermally administered flunixin.  相似文献   
166.
167.
A retrospective study was conducted to determine case histories, microbiological characteristics, and molecular subtypes associated with Listeria monocytogenes infections of the eye in large animals. For selected cases, environmental L. monocytogenes contamination patterns on case farms were also evaluated to probe for potential sources and spread of listerial eye infections. Records of 170 L. monocytogenes isolates from animal infections were reviewed to determine the fraction of isolates associated with eye infections (conjunctivitis, keratitis, and uveitis) of animals and to gather information on the clinical history of these cases. Overall, 4 of 170 Listeria monocytogenes isolates were associated with eye infections; 3 of these had occurred in cows and 1 in a horse. Molecular subtyping (by EcoRI ribotying) showed that 4 different L. monocytogenes subtypes were isolated from these 4 cases; the same ribotypes had previously been found among invasive animal listeriosis infections. Although a variety of L. monocytogenes subtypes were isolated from environmental sources, on 1 farm, the same ribotype associated with the eye infection was also isolated from a fecal sample of a healthy animal and from a soil sample. The data reported in this study further suggest that L. monocytogenes can be a cause of eye infections in several animal species. Listerial eye infections do not seem to require specific pathogen-related virulence characteristics but rather seem to be a function of environmental or host factors, such as direct exposure of the eyes of susceptible animals to high numbers of the pathogen. Although listerial eye infections are rarely diagnosed because of its ubiquitous nature, L. monocytogenes may have to be considered more commonly as a causative agent of eye infections in ruminants and horses.  相似文献   
168.
A 1-year-old, female English Bulldog presented with a 10-day history of progressive paraparesis. Neuroanatomical localization was consistent with T3-L3 segment myelopathy. Magnetic resonance imaging (MRI) revealed a severely compressive, mildly contrast enhancing, extradural, dorsal, broad-based mass at the level of L3-4. Similar, non-compressive, smaller nodules were present along the extradural space and dura mater of the caudal lumbar spine. Owners elected euthanasia based on these imaging findings and progressive clinical signs. Necropsy, histopathology and immunohistochemistry revealed a mesenchymal mass and nodules, admixed with numerous inflammatory cells. The diagnosis of an extradural inflammatory myofibroblastic tumor (IMT) with a multifocal presentation was made.  相似文献   
169.
170.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号